Further characterization of RON signaling in the myeloid compartment in supporting prostate tumor development was performed using a myeloid lineage-specific RON-deficient mouse model (RON TKFL/FL, LysM-Cre) [95]. This evidence concerns the gene MST1R and prostate neoplasm.